Invention Grant
- Patent Title: Recombinant novirhabdovirus usable as an antigen vector
-
Application No.: US14435981Application Date: 2013-10-08
-
Publication No.: US09907843B2Publication Date: 2018-03-06
- Inventor: Michel Bremont , Angella Nzonza
- Applicant: Institut National de la Recherche Agronomique
- Applicant Address: FR Paris
- Assignee: Institut National de la Recherche Agronomique
- Current Assignee: Institut National de la Recherche Agronomique
- Current Assignee Address: FR Paris
- Agency: Morgan, Lewis & Bockius LLP
- Priority: FR1259815 20121015
- International Application: PCT/IB2013/059207 WO 20131008
- International Announcement: WO2014/060905 WO 20140424
- Main IPC: A61K39/205
- IPC: A61K39/205 ; A61K39/12 ; C12N15/86 ; C12N7/00 ; A61K39/00

Abstract:
The invention relates to a recombinant novirhabdovirus expressing a chimeric protein comprising the sequence of an antigen of interest flanked, at the N-terminus, by a signal peptide, and at the C-terminus, by a polypeptide comprising at least one portion of the transmembrane domain of a rhabdovirus G protein. Said recombinant novirhabdovirus can be used especially for inducing an immune response to the antigen of interest.
Public/Granted literature
- US20150265699A1 Recombinant Novirhabdovirus Usable as an Antigen Vector Public/Granted day:2015-09-24
Information query